SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PROTEOMICS
An SI Board Since January 2000
Posts SubjectMarks Bans
539 50 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
114BILLERICA, Mass. & EVANSTON, Ill.--(BUSINESS WIRE)--Sept. 12, 2000-- Genevanigel bates-9/13/2000
113Someone asked me for a list of 'proteomics companies' recently. FWIW, henigel bates-9/13/2000
112Re: CYTO, company press release; high throughput protein interaction measurementSidney Street-9/12/2000
111Subject 36435$Mogul-9/8/2000
110Here's a good overview on the subject, from the Economist: economist.comSidney Street-9/8/2000
109Appreciated your comments in this matter.greedsgd_2000-9/8/2000
108<i>expression patterns..... of an individual's entire genome</i>scaram(o)uche-9/7/2000
107PROTEOMICS QUESTION: In June after the CRA announcement, AFFX issued a press regreedsgd_2000-9/7/2000
106CYTO. Presenting at the SF conference on September 22, just enteres into an agratskaggs-9/6/2000
105GENEVA and SYDNEY, Australia, Sept. 5 /PRNewswire/ -- Proteome Systems and GeneBnigel bates-9/5/2000
104Sept. 5 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (``Isis'') (Nasdaq: Inigel bates-9/5/2000
103Sept. 5 /PRNewswire/ -- Myriad Genetics, Inc. (Nasdaq: MYGN - news) announced tonigel bates-9/5/2000
102From Sequitur site - "Richard Wagner, Ph.D. Dr. Wagner serves on Sequitur&nigel bates-9/4/2000
101Aug. 31, 2000--Cytoclonal Pharmaceutics Inc. (NASDAQ: CYPH - news) announced todnigel bates-8/31/2000
100CEREP (FR) Announces Drug Discovery Collaboration with Solvay cerep.fr martinJongmans-8/29/2000
99<i>Starting with synthetic, semi-synthetic, and/or cellular DNA, Phylos hascaram(o)uche-8/24/2000
98Definitely both as far as I'm concerned. nignigel bates-8/24/2000
97... "Drug Discovery The ability to generate and evolve large peptide andnigel bates-8/24/2000
96... "Phylos has developed a unique target identification platform for studnigel bates-8/24/2000
95And... "Phylos is developing the PROfile™ chip, the first high-throughput nigel bates-8/24/2000
94From the website - "Phylos’ proprietary PROfusion™ technology enables the nigel bates-8/24/2000
93<i>The fundamental advance is the in vitro covalent linkage of a protein scaram(o)uche-8/24/2000
92Aug. 24 /PRNewswire/ -- Phylos, Inc. today announced the achievement of key milenigel bates-8/24/2000
91CEREP (Fr) announced significant progress in its collaboration with bristol-MyerJongmans-8/24/2000
90iconixpharm.com Query genes for Iconix assay construction may be from diverse scaram(o)uche-8/22/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News